New York, NY, United States of America

Nina C Shaplely


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nina C. Shaplely: Innovator in Blood-Based Therapies

Introduction

Nina C. Shaplely is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medical technology, particularly in blood-based therapies. Her innovative work focuses on improving the purification of sample fluids, which has important implications for healthcare.

Latest Patents

Nina C. Shaplely holds 1 patent for her invention titled "Systems and methods of blood-based therapies having a microfluidic membraneless exchange device." This invention is directed to devices, systems, and methods for removing undesirable materials from a sample fluid by contact with a second fluid. The sample fluid flows as a thin layer adjacent to, or between, concurrently flowing layers of the second fluid, without an intervening membrane. The invention is particularly useful in various situations where a sample fluid is to be purified via a diffusion mechanism against an extractor fluid.

Career Highlights

Nina is affiliated with Columbia University, where she continues her research and development in innovative medical technologies. Her work has the potential to enhance the efficacy of blood purification processes, benefiting patients in need of advanced therapeutic solutions.

Collaborations

Nina has collaborated with notable colleagues, including Edward F. Leonard and Alan C. West. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Nina C. Shaplely is a trailblazer in the field of blood-based therapies, with her innovative patent showcasing her commitment to improving medical technology. Her work at Columbia University and collaborations with esteemed colleagues further highlight her impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…